International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine
Francesca Puledda(King's College London), Simona Sacco(University of L'Aquila), Hans‐Christoph Diener(University of Duisburg-Essen), Messoud Ashina(University of Copenhagen), Haidar M. Al‐Khazali(Copenhagen University Hospital), Sait Ashina(University of Copenhagen), Rami Burstein(Beth Israel Deaconess Medical Center), Eric Liebler(International Headache Society), Andrea Cipriani(Oxford Health NHS Foundation Trust), Min Kyung Chu(Yonsei University), Alexandra Cocores(University of Miami), Freda Dodd-Glover(Korle Bu Teaching Hospital), Esme Ekizoğlu(Istanbul University), David García‐Azorín(Universidad de Valladolid), Carl H. Göbel(Christian-Albrechts-Universität zu Kiel), María Teresa Goicochea, Amr Hassan(Cairo University), Koichi Hirata(Dokkyo Medical University), Jan Hoffmann(King's College London), Bronwyn Jenkins(Royal North Shore Hospital), Katharina Kamm(LMU Klinikum), Mi Ji Lee(Seoul National University Hospital), Yu‐Hsiang Ling(National Yang Ming Chiao Tung University), Marco Lisicki(Consejo Nacional de Investigaciones Científicas y Técnicas), Daniele Martinelli, Teshamae Monteith(University of Miami), Raffaele Ornello(University of L'Aquila), Aynur Özge(Mersin Üniversitesi), Mário Fernando Prieto Peres, Patricia Pozo‐Rosich, V.I. Romanenko, Todd J. Schwedt(Mayo Clinic Hospital), Marcio Nattan Portes Souza(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Tsubasa Takizawa(Keio University), Gisela M. Terwindt(Leiden University Medical Center), Janu Thuraiaiyah(Copenhagen University Hospital), Mansoureh Togha(Sina Hospital), Nicolas Vandenbussche(Ghent University Hospital), Shuu‐Jiun Wang(National Yang Ming Chiao Tung University), Shenguan Yu(Chinese PLA General Hospital), Cristina Tassorelli(University of Pavia)
Cited by 97Open Access
Abstract
Consistent with the mission of the International Headache Society (IHS) to improve migraine management worldwide, this document focuses on providing practical recommendations on the preventive pharmacological management of migraine. Due to the inconsistent availability of medications across different regions of the globe, these recommendations are categorized into two levels: Optimal and Essential. The Optimal level is intended for settings where most drug treatments are available. The Essential level is focused on countries where only the drugs listed in the World Health Organization (WHO) Model List of Essential Medicines (EML) are available
Related Papers
No related papers found
Powered by citation graph analysis